Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 10
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy.
Diez P, Hanna GG, Aitken KL, van As N, Carver A, Colaco RJ, Conibear J, Dunne EM, Eaton DJ, Franks KN, Good JS, Harrow S, Hatfield P, Hawkins MA, Jain S, McDonald F, Patel R, Rackley T, Sanghera P, Tree A, Murray L. Diez P, et al. Clin Oncol (R Coll Radiol). 2022 May;34(5):288-300. doi: 10.1016/j.clon.2022.02.010. Epub 2022 Mar 7. Clin Oncol (R Coll Radiol). 2022. PMID: 35272913
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall E, van As N; PACE Trial Investigators. Tree AC, et al. Lancet Oncol. 2022 Oct;23(10):1308-1320. doi: 10.1016/S1470-2045(22)00517-4. Epub 2022 Sep 13. Lancet Oncol. 2022. PMID: 36113498 Free article. Clinical Trial.
Integrated MRI-guided radiotherapy - opportunities and challenges.
Keall PJ, Brighi C, Glide-Hurst C, Liney G, Liu PZY, Lydiard S, Paganelli C, Pham T, Shan S, Tree AC, van der Heide UA, Waddington DEJ, Whelan B. Keall PJ, et al. Nat Rev Clin Oncol. 2022 Jul;19(7):458-470. doi: 10.1038/s41571-022-00631-3. Epub 2022 Apr 19. Nat Rev Clin Oncol. 2022. PMID: 35440773 Review.
Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is Recruiting.
Kirby AM, Haviland JS, Mackenzie M, Fleming H, Anandadas C, Wickers S, Miles E, Iles N, Bliss JM, Coles CE; PARABLE Trial Management Group. Kirby AM, et al. Clin Oncol (R Coll Radiol). 2023 Jun;35(6):347-350. doi: 10.1016/j.clon.2023.02.015. Epub 2023 Mar 2. Clin Oncol (R Coll Radiol). 2023. PMID: 36933970 No abstract available.
HERMES: Delivery of a Speedy Prostate Cancer Treatment.
Westley R, Hall E, Tree A. Westley R, et al. Clin Oncol (R Coll Radiol). 2022 Jul;34(7):426-429. doi: 10.1016/j.clon.2022.01.003. Epub 2022 Jan 31. Clin Oncol (R Coll Radiol). 2022. PMID: 35093251 Free PMC article. No abstract available.
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus.
Spohn SKB, Draulans C, Kishan AU, Spratt D, Ross A, Maurer T, Tilki D, Berlin A, Blanchard P, Collins S, Bronsert P, Chen R, Pra AD, de Meerleer G, Eade T, Haustermans K, Hölscher T, Höcht S, Ghadjar P, Davicioni E, Heck M, Kerkmeijer LGW, Kirste S, Tselis N, Tran PT, Pinkawa M, Pommier P, Deltas C, Schmidt-Hegemann NS, Wiegel T, Zilli T, Tree AC, Qiu X, Murthy V, Epstein JI, Graztke C, Gao X, Grosu AL, Kamran SC, Zamboglou C. Spohn SKB, et al. Int J Radiat Oncol Biol Phys. 2023 Jul 1;116(3):503-520. doi: 10.1016/j.ijrobp.2022.12.038. Epub 2022 Dec 31. Int J Radiat Oncol Biol Phys. 2023. PMID: 36596346 Free article. Review.
Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).
Ma TM, Chu FI, Sandler H, Feng FY, Efstathiou JA, Jones CU, Roach M 3rd, Rosenthal SA, Pisansky T, Michalski JM, Bolla M, de Reijke TM, Maingon P, Neven A, Denham J, Steigler A, Joseph D, Nabid A, Souhami L, Carrier N, Incrocci L, Heemsbergen W, Pos FJ, Sydes MR, Dearnaley DP, Tree AC, Syndikus I, Hall E, Cruickshank C, Malone S, Roy S, Sun Y, Zaorsky NG, Nickols NG, Reiter RE, Rettig MB, Steinberg ML, Reddy VK, Xiang M, Romero T, Spratt DE, Kishan AU; Meta-analysis of Randomized trials in Cancer of the Prostate MARCAP Consortium investigators. Ma TM, et al. Eur Urol. 2022 Nov;82(5):487-498. doi: 10.1016/j.eururo.2022.07.011. Epub 2022 Aug 5. Eur Urol. 2022. PMID: 35934601 Free article. Review.
17 results